IBIO: iBio, Inc. Stock

by  •  • Comments Off on IBIO: iBio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 13.17
Enterprise Value ($M) 10.13
Book Value ($M) 11.38
Book Value / Share 0.69
Price / Book 1.16
NCAV ($M) -1.66
NCAV / Share -0.10
Price / NCAV -7.92

Profitability (mra)
Return on Invested Capital (ROIC) -1.28
Return on Assets (ROA) -0.42
Return on Equity (ROE) -0.84

Liquidity (mrq)
Quick Ratio 1.12
Current Ratio 1.12

Balance Sheet (mrq) ($M)
Current Assets 6.06
Assets 19.10
Liabilities 7.72
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Opaleye Management Inc. 7.60 15.38
02-14 13G/A ADAR1 Capital Management, LLC 9.99 13.42
01-30 13G/A Crutcher Patrick J 7.00
01-03 13G/A Sabby Management, Llc 0.20 -90.39
11-14 13G Ikarian Capital, LLC 6.60

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-13 117,259 398,154 29.45
2025-05-12 190,547 816,223 23.34
2025-05-09 125,071 410,040 30.50
2025-05-08 317,520 1,598,939 19.86

(click for more detail)

Similar Companies
HOOK – HOOKIPA Pharma Inc. HOTH – Hoth Therapeutics, Inc.
HRTX – Heron Therapeutics, Inc. ICCC – ImmuCell Corporation
IKT – Inhibikase Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io